Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website
Rhea-AI Summary
Haemonetics (NYSE: HAE) announced the availability of its second quarter fiscal year 2025 financial results, ended September 28, 2024, on its Investor Relations website. The company will host a conference call and webcast with investors and analysts on November 7, 2024, at 8:00 a.m. ET to discuss the results. Participants are recommended to join 10 minutes before the event starts. A replay of the conference call and webcast will be available for one year starting November 7, 2024, at 11:00 a.m. ET.
Positive
- None.
Negative
- None.
Insights
The announcement of an upcoming earnings release and conference call, without the actual financial figures, does not provide actionable information for investors. This is a routine administrative announcement that precedes the actual earnings release and discussion. Investors should wait for the actual earnings call and financial results to make informed decisions about HAE stock.
Financial release accessible online
The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on November 7, 2024. The conference call and webcast can be accessed with the following information:
- Teleconference link: https://register.vevent.com/register/BI3c9f473811f94c489025845778f9dabc
- Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.
- A live webcast of the call can be accessed on Haemonetics' investor relations website or via the following link: https://edge.media-server.com/mmc/p/rcm5foqd
In addition, the Company has posted to its Investor Relations website the earnings release that will be referenced on its conference call and webcast, a link to which is available below.
Direct link to 2Q FY25 Earnings Release:
https://haemonetics.gcs-web.com/static-files/a28cb934-1e51-4489-9c9f-1a3f68dc7f5a
A replay of the conference call and webcast will be available for one year beginning on November 7, 2024, at 11:00 a.m. ET using the conference call webcast link provided in this press release.
ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts: | |
Olga Guyette, Vice President-Investor Relations & Treasury | David Trenk, Manager-Investor Relations |
(781) 356-9763 | (203) 733-4987 |
Media Contact: | |
Josh Gitelson, Sr. Director-Global Communications | |
(781) 356-9776 | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-2nd-quarter-fiscal-year-2025-earnings-release-available-on-investor-relations-website-302298494.html
SOURCE Haemonetics Corporation
FAQ
When will Haemonetics (HAE) release Q2 FY2025 earnings?
How can I access Haemonetics (HAE) Q2 FY2025 earnings call?
How long will Haemonetics (HAE) Q2 FY2025 earnings call replay be available?
